Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yu Imai

Showing results (21-30 of 73) with videos related to

Pageof 8
Sort By:
Applied and Environmental Microbiology|September 24, 2025
A novel homoarginine-containing cyclic peptide pioamide with selective antipseudomonal activity isolated from the nematode symbiont <i>Photorhabdus khanii</i>Yu Imai, Sangkeun Son, Miho Sasaki, et al.
International Archives of Allergy and Immunology|May 26, 2012
Elevated numbers of cells producing interleukin-5 and interleukin-10 in a boy with Kimura diseaseKoa Hosoki, Masahiro Hirayama, Gail M Kephart, et al.
Translational Andrology and Urology|October 22, 2024
Optimizing prostate cancer detection in transition zone: an analysis of apparent diffusion coefficient values in prostate magnetic resonance imaging evaluation with Prostate Imaging Reporting and Data System (PI-RADS) assessmentYu Imai, Fumihiko Urabe, Ibuki Sadakane, et al.
IJU Case Reports|July 7, 2022
Laparoscopic partial nephrectomy for the horseshoe kidney with indocyanine green fluorescence guidance under the modified supine positionYu Imai, Fumihiko Urabe, Wataru Fukuokaya, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|August 31, 2023
Patients with PSA below 0.2 ng/mL at 8 years post high-dose-rate brachytherapy have an extremely low risk of subsequent recurrenceMinoru Nakazono, Fumihiko Urabe, Kosuke Iwatani, et al.
Nature|April 15, 2021
The antibiotic darobactin mimics a β-strand to inhibit outer membrane insertaseHundeep Kaur, Roman P Jakob, Jan K Marzinek, et al.
International Journal of Clinical Oncology|May 25, 2023
The prognostic significance of the clinical T stage and Grade Group in patients with locally advanced prostate cancer treated via high-dose-rate brachytherapy and external beam radiationSoshi Kadena, Fumihiko Urabe, Kosuke Iwatani, et al.
International Cancer Conference Journal|October 14, 2024
A case of pagetoid spread of urothelial carcinoma with notable reduction achieved through enfortumab vedotin, resulting in complete surgical resectionKenichi Tokuoka, Katsuki Muramoto, Keigo Sakanaka, et al.
The Prostate|August 4, 2019
No survival benefit found after extended treatment with docetaxel for patients with castration-resistant prostate cancerMasatoshi Tanaka, Takahiro Kimura, Yumina Iwamura, et al.
Cancer Immunology, Immunotherapy : CII|September 14, 2022
Effectiveness of pembrolizumab in trial-ineligible patients with metastatic urothelial carcinomaWataru Fukuokaya, Takafumi Yanagisawa, Masaki Hashimoto, et al.
Pageof 8

Showing results (21-30 of 73) with videos related to

Sort By:
Pageof 8
Applied and Environmental Microbiology|September 24, 2025
A novel homoarginine-containing cyclic peptide pioamide with selective antipseudomonal activity isolated from the nematode symbiont <i>Photorhabdus khanii</i>Yu Imai, Sangkeun Son, Miho Sasaki, et al.
International Archives of Allergy and Immunology|May 26, 2012
Elevated numbers of cells producing interleukin-5 and interleukin-10 in a boy with Kimura diseaseKoa Hosoki, Masahiro Hirayama, Gail M Kephart, et al.
Translational Andrology and Urology|October 22, 2024
Optimizing prostate cancer detection in transition zone: an analysis of apparent diffusion coefficient values in prostate magnetic resonance imaging evaluation with Prostate Imaging Reporting and Data System (PI-RADS) assessmentYu Imai, Fumihiko Urabe, Ibuki Sadakane, et al.
IJU Case Reports|July 7, 2022
Laparoscopic partial nephrectomy for the horseshoe kidney with indocyanine green fluorescence guidance under the modified supine positionYu Imai, Fumihiko Urabe, Wataru Fukuokaya, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|August 31, 2023
Patients with PSA below 0.2 ng/mL at 8 years post high-dose-rate brachytherapy have an extremely low risk of subsequent recurrenceMinoru Nakazono, Fumihiko Urabe, Kosuke Iwatani, et al.
Nature|April 15, 2021
The antibiotic darobactin mimics a β-strand to inhibit outer membrane insertaseHundeep Kaur, Roman P Jakob, Jan K Marzinek, et al.
International Journal of Clinical Oncology|May 25, 2023
The prognostic significance of the clinical T stage and Grade Group in patients with locally advanced prostate cancer treated via high-dose-rate brachytherapy and external beam radiationSoshi Kadena, Fumihiko Urabe, Kosuke Iwatani, et al.
International Cancer Conference Journal|October 14, 2024
A case of pagetoid spread of urothelial carcinoma with notable reduction achieved through enfortumab vedotin, resulting in complete surgical resectionKenichi Tokuoka, Katsuki Muramoto, Keigo Sakanaka, et al.
The Prostate|August 4, 2019
No survival benefit found after extended treatment with docetaxel for patients with castration-resistant prostate cancerMasatoshi Tanaka, Takahiro Kimura, Yumina Iwamura, et al.
Cancer Immunology, Immunotherapy : CII|September 14, 2022
Effectiveness of pembrolizumab in trial-ineligible patients with metastatic urothelial carcinomaWataru Fukuokaya, Takafumi Yanagisawa, Masaki Hashimoto, et al.
Pageof 8